News Release Details

Mar 28, 2018
Magellan Health to Participate at Nephron Research Pharma Pricing and Benefit Management Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Mar. 28, 2018-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan Rx Management, and Casey Stockman, vice president medical pharmacy for Magellan Rx Management, will participate in a panel discussion at the Nephron Research Pharma Pricing and Benefit Management Symposium on Thursday, April 12, 2018, at the Benjamin Hotel in New York. Panel members will discuss real world examples of managing the pharmacy spend covered under the medical benefit.

About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit


Source: Magellan Health, Inc.

Magellan Health, Inc.
Media Contact:
Lilly Ackley, 860-507-1923
Investor Contact:
Joe Bogdan, 860-507-1910